Perrigo Company (PRGO) Stock Forecast, Price Target & Predictions
PRGO Stock Forecast
Perrigo Company stock forecast is as follows: an average price target of $30.00 (represents a 16.50% upside from PRGO’s last price of $25.75) and a rating consensus of 'Hold', based on 9 wall street analysts offering a 1-year stock forecast.
PRGO Price Target
PRGO Analyst Ratings
Hold
Perrigo Company Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Sep 23, 2024 | Keith Devas | Jefferies | $30.00 | $27.06 | 10.86% | 16.50% |
Jun 13, 2024 | Korinne Wolmeyer | Piper Sandler | $36.00 | $27.84 | 29.31% | 39.81% |
Apr 08, 2024 | Korinne Wolmeyer | Piper Sandler | $39.00 | $31.40 | 24.20% | 51.46% |
Nov 17, 2023 | Korinne Wolfmeyer | Piper Sandler | $37.00 | $30.07 | 23.04% | 43.69% |
Sep 06, 2022 | Jacob Hughes | Wells Fargo | $54.00 | $36.74 | 46.98% | 109.71% |
May 04, 2022 | Raymond James | $48.00 | $32.76 | 46.54% | 86.41% |
Perrigo Company Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | 1 | 3 |
Avg Price Target | - | $30.00 | $35.00 |
Last Closing Price | $25.75 | $25.75 | $25.75 |
Upside/Downside | -100.00% | 16.50% | 35.92% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Jun 13, 2024 | Piper Sandler | Overweight | Overweight | Hold |
Apr 08, 2024 | Piper Sandler | Overweight | Overweight | Hold |
Oct 03, 2022 | Raymond James | Outperform | Outperform | Hold |
Sep 14, 2022 | Bernstein | Market Perform | Downgrade | |
Sep 14, 2022 | Guggenheim | Neutral | Downgrade | |
Sep 14, 2022 | B. Riley Securities | Buy | Initialise | |
Sep 14, 2022 | Morgan Stanley | Equal-Weight | Downgrade | |
Sep 14, 2022 | Wells Fargo | Overweight | Equal-Weight | Downgrade |
Sep 14, 2022 | Jefferies | Hold | Downgrade | |
Sep 14, 2022 | Argus Research | Buy | Upgrade | |
Sep 14, 2022 | Raymond James | Outperform | Upgrade | |
Sep 06, 2022 | Wells Fargo | Overweight | Upgrade |
Perrigo Company Financial Forecast
Perrigo Company Revenue Forecast
Quarter
Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.16B | $1.12B | $1.19B | $1.18B | $1.16B | $1.10B | $1.12B | $1.07B | $1.10B | $1.04B | $981.10M | $1.01B | $1.29B | $1.21B |
Avg Forecast | $1.35B | $1.21B | $1.18B | $1.22B | $1.29B | $1.15B | $1.14B | $1.15B | $1.24B | $1.12B | $1.12B | $1.13B | $1.20B | $1.12B | $1.10B | $1.09B | $1.17B | $1.20B | $1.18B | $1.17B | $1.20B | $1.14B | $1.06B | $1.06B | $1.10B | $1.05B | $1.02B | $1.02B | $1.32B | $1.24B |
High Forecast | $1.36B | $1.22B | $1.19B | $1.23B | $1.29B | $1.16B | $1.14B | $1.16B | $1.25B | $1.13B | $1.13B | $1.14B | $1.22B | $1.13B | $1.11B | $1.09B | $1.20B | $1.20B | $1.19B | $1.18B | $1.21B | $1.14B | $1.06B | $1.06B | $1.10B | $1.05B | $1.02B | $1.02B | $1.32B | $1.24B |
Low Forecast | $1.34B | $1.20B | $1.17B | $1.20B | $1.27B | $1.14B | $1.12B | $1.14B | $1.23B | $1.11B | $1.11B | $1.12B | $1.18B | $1.12B | $1.08B | $1.09B | $1.14B | $1.20B | $1.17B | $1.16B | $1.19B | $1.14B | $1.06B | $1.06B | $1.10B | $1.05B | $1.02B | $1.02B | $1.32B | $1.24B |
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 4 | 3 | 2 | 2 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 9 | 15 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.98% | 0.94% | 1.01% | 1.01% | 0.96% | 0.96% | 1.05% | 1.02% | 1.01% | 0.99% | 0.96% | 0.99% | 0.98% | 0.98% |
Forecast
Perrigo Company EBITDA Forecast
Quarter
Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 4 | 3 | 2 | 2 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 9 | 15 |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $-15.50M | $184.10M | $56.80M | $140.10M | $134.00M | $144.70M | $32.30M | $95.90M | $91.30M | $488.30M | $3.60M | $174.70M | $-80.70M | $3.20M |
Avg Forecast | $193.84M | $173.61M | $169.43M | $174.52M | $184.19M | $165.13M | $162.82M | $165.45M | $178.06M | $160.94M | $160.42M | $161.73M | $172.15M | $160.74M | $157.35M | $154.10M | $168.32M | $171.98M | $169.19M | $140.09M | $76.39M | $213.88M | $199.42M | $110.74M | $205.91M | $196.97M | $190.64M | $196.15M | $246.97M | $231.42M |
High Forecast | $195.17M | $174.80M | $170.59M | $175.71M | $185.45M | $166.26M | $163.94M | $166.58M | $179.28M | $162.04M | $161.52M | $162.84M | $175.02M | $161.62M | $159.30M | $184.92M | $172.56M | $172.17M | $170.34M | $168.11M | $91.66M | $213.88M | $199.42M | $132.89M | $205.91M | $196.97M | $190.64M | $235.39M | $246.97M | $231.42M |
Low Forecast | $191.55M | $171.56M | $167.43M | $172.45M | $182.01M | $163.18M | $160.90M | $163.50M | $175.95M | $159.03M | $158.53M | $160.31M | $169.28M | $159.86M | $155.41M | $123.28M | $162.66M | $171.79M | $167.19M | $112.07M | $61.11M | $213.88M | $199.42M | $88.59M | $205.91M | $196.97M | $190.64M | $156.92M | $246.97M | $231.42M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -0.09% | 1.07% | 0.34% | 1.00% | 1.75% | 0.68% | 0.16% | 0.87% | 0.44% | 2.48% | 0.02% | 0.89% | -0.33% | 0.01% |
Forecast
Perrigo Company Net Income Forecast
Quarter
Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 4 | 3 | 2 | 2 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 9 | 15 |
Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $-32.30M | $14.20M | $8.40M | $-1.10M | $-12.70M | $-52.10M | $-64.90M | $-1.30M | $32.10M | $-53.90M | $-111.90M | $2.80M | $-175.00M | $-154.60M |
Avg Forecast | $134.75M | $123.75M | $119.63M | $121.00M | $134.69M | $111.83M | $106.42M | $106.88M | $126.29M | $101.66M | $98.15M | $96.82M | $130.27M | $111.58M | $65.12M | $-4.06M | $114.13M | $86.12M | $70.29M | $-3.69M | $-21.10M | $91.61M | $60.32M | $-2.91M | $77.23M | $89.57M | $81.92M | $42.78M | $137.44M | $115.34M |
High Forecast | $135.95M | $124.85M | $120.69M | $122.07M | $135.88M | $112.82M | $107.36M | $107.83M | $127.41M | $102.57M | $99.02M | $113.73M | $134.51M | $113.54M | $66.20M | $-3.24M | $116.88M | $87.04M | $70.92M | $-2.95M | $-16.88M | $91.61M | $60.32M | $-2.33M | $77.23M | $89.57M | $81.92M | $51.33M | $137.44M | $115.34M |
Low Forecast | $132.68M | $121.85M | $117.79M | $119.14M | $132.62M | $110.11M | $104.78M | $105.24M | $124.35M | $100.10M | $96.64M | $79.92M | $126.02M | $109.62M | $64.05M | $-4.87M | $107.25M | $85.21M | $69.21M | $-4.42M | $-25.31M | $91.61M | $60.32M | $-3.50M | $77.23M | $89.57M | $81.92M | $34.22M | $137.44M | $115.34M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -0.28% | 0.16% | 0.12% | 0.30% | 0.60% | -0.57% | -1.08% | 0.45% | 0.42% | -0.60% | -1.37% | 0.07% | -1.27% | -1.34% |
Forecast
Perrigo Company SG&A Forecast
Quarter
Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 4 | 3 | 2 | 2 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 9 | 15 |
SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $152.50M | $304.00M | $171.10M | $331.50M | $308.60M | $281.00M | $338.10M | $282.30M | $269.30M | $283.60M | $274.30M | $284.20M | $330.00M | $281.00M |
Avg Forecast | $348.39M | $312.03M | $304.51M | $313.66M | $331.04M | $296.79M | $292.64M | $297.36M | $320.02M | $289.25M | $288.32M | $290.68M | $309.40M | $288.89M | $282.81M | $477.00M | $302.52M | $309.09M | $304.08M | $433.63M | $320.43M | $294.02M | $274.14M | $342.79M | $283.06M | $270.77M | $262.08M | $319.10M | $339.51M | $318.12M |
High Forecast | $350.77M | $314.16M | $306.59M | $315.80M | $333.30M | $298.81M | $294.64M | $299.39M | $322.21M | $291.22M | $290.29M | $292.66M | $314.55M | $290.48M | $286.31M | $572.40M | $310.14M | $309.43M | $306.15M | $520.36M | $384.51M | $294.02M | $274.14M | $411.35M | $283.06M | $270.77M | $262.08M | $382.92M | $339.51M | $318.12M |
Low Forecast | $344.27M | $308.34M | $300.91M | $309.95M | $327.12M | $293.28M | $289.18M | $293.85M | $316.24M | $285.83M | $284.91M | $288.13M | $304.24M | $287.31M | $279.31M | $381.60M | $292.35M | $308.75M | $300.48M | $346.91M | $256.34M | $294.02M | $274.14M | $274.23M | $283.06M | $270.77M | $262.08M | $255.28M | $339.51M | $318.12M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.50% | 0.98% | 0.56% | 0.76% | 0.96% | 0.96% | 1.23% | 0.82% | 0.95% | 1.05% | 1.05% | 0.89% | 0.97% | 0.88% |
Forecast
Perrigo Company EPS Forecast
Quarter
Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 4 | 3 | 2 | 2 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 9 | 15 |
EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $-0.24 | $0.10 | $0.06 | $-0.01 | $-0.09 | $-0.39 | $-0.48 | $-0.01 | $0.24 | $-0.40 | $-0.84 | $0.29 | $-1.29 | $-1.13 |
Avg Forecast | $0.98 | $0.90 | $0.87 | $0.88 | $0.98 | $0.81 | $0.77 | $0.78 | $0.92 | $0.74 | $0.71 | $0.70 | $0.95 | $0.81 | $0.47 | $0.23 | $0.83 | $0.63 | $0.51 | $0.43 | $0.70 | $0.67 | $0.44 | $0.42 | $0.56 | $0.65 | $0.60 | $0.57 | $1.00 | $0.84 |
High Forecast | $0.99 | $0.91 | $0.88 | $0.89 | $0.99 | $0.82 | $0.78 | $0.78 | $0.93 | $0.75 | $0.72 | $0.83 | $0.98 | $0.83 | $0.48 | $0.24 | $0.85 | $0.63 | $0.52 | $0.43 | $0.71 | $0.67 | $0.44 | $0.42 | $0.56 | $0.65 | $0.60 | $0.57 | $1.00 | $0.84 |
Low Forecast | $0.96 | $0.89 | $0.86 | $0.87 | $0.96 | $0.80 | $0.76 | $0.77 | $0.90 | $0.73 | $0.70 | $0.58 | $0.92 | $0.80 | $0.47 | $0.23 | $0.78 | $0.62 | $0.50 | $0.42 | $0.69 | $0.67 | $0.44 | $0.42 | $0.56 | $0.65 | $0.60 | $0.57 | $1.00 | $0.84 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -0.29% | 0.16% | 0.12% | -0.02% | -0.13% | -0.58% | -1.09% | -0.02% | 0.43% | -0.61% | -1.41% | 0.51% | -1.29% | -1.34% |
Forecast
Perrigo Company Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
KMDA | Kamada | $5.75 | $20.00 | 247.83% | |
AMPH | Amphastar Pharmaceuticals | $40.85 | $66.00 | 61.57% | Buy |
ELAN | Elanco Animal Health | $12.31 | $17.50 | 42.16% | Buy |
ANIP | ANI Pharmaceuticals | $55.83 | $79.00 | 41.50% | Buy |
COLL | Collegium Pharmaceutical | $30.90 | $42.33 | 36.99% | Buy |
PCRX | Pacira BioSciences | $19.83 | $23.75 | 19.77% | Hold |
PRGO | Perrigo Company | $26.41 | $30.00 | 13.59% | Hold |
PBH | Prestige Consumer Healthcare | $80.39 | $89.50 | 11.33% | Buy |
PAHC | Phibro Animal Health | $22.34 | $18.67 | -16.43% | Buy |